hVIVO plc

hVIVO plc

OPORF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$54.25M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
hVIVO plchVIVO plc-2.8-60%-0.3
$0.06

Current Fair Value

18.1% downside

Overvalued by 18.1% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$54.25 Million
Enterprise Value$23.82 Million
Earnings per Share$-0.01
Beta1.71
Outstanding Shares687,966,692

Return

Return on Equity59.91%ROE
Return on Assets30.11%
Return on Invested Capital39.72%

Valuation & Multiples

P/E Ratio-2.81P/E Ratio
PEG5.03PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue0.2
Enterprise Value to EBIT1.05
Enterprise Value to Net Income0
Total Debt to Enterprise0.58
Debt to Equity0.31Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
September 15, 2026
EPS
-$0.01
Reported
Revenue
$21.57 M
Est. $21.61 M

Next Earnings Call

Expected Date
April 14, 2027
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
$22.74 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About hVIVO plc

376 employees
CEO: Yamin Mohammed Khan

hVIVO plc (HVO) operates as a premier full-service Contract Research Organisation (CRO) focused on early-phase clinical development, globally recognized as the leader in human challenge trials. The company provides a complete spectrum of...